title: Mesenchymal stem cells: new aspect in cell-based regenerative therapy.
abstract: MSCs are multipotent progenitors which reside in bone marrow. They support hematopoietic stem cells homing, self renewal and differentiation in bone marrow. They can also differentiate into osteoblasts, adipocytes, chondrocytes, myocyates and many other tissues. In vivo, when trauma happens, MSCs operate cell renewal and migrate to the damaged tissues to regenerate that injury. In vitro, MSCs are able to proliferate and differentiate to a variety of cell lineages. This makes them a very hopeful tool for cell-based regenerative therapy for large bone defects, maxillofacial skeletal reconstruction, cardiovascular and spinal cord injury and so many other defects. The most important characteristic that make MSCs an excellent tool for cell replacement is their ability to escape from immune rejection. For therapeutic purposes they usually isolated from human bone marrow or fat and they should proliferate in order to reach an adequate number for implantation. Conventionally DMEM medium supplemented with 10% FBS is used for their expansion, but currently autologous platelet rich products are replaced FBS. Platelet granules contain so many growth factors that can support MSCs proliferation.
authors: Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
authors: Mozhdeh
authors: M
authors: Mohammadian
authors: Karim
authors: K
authors: Shamsasenjan
authors: Parisa
authors: P
authors: Lotfi Nezhad
authors: Mehdi
authors: M
authors: Talebi
authors: Mehdi
authors: M
authors: Jahedi
authors: Hossein
authors: H
authors: Nickkhah
authors: Neda
authors: N
authors: Minayi
authors: Aliakbar
authors: A
authors: Movassagh Pour
keywords: Autologous platelet rich product; Cell-based regenerative therapy; Mesenchymal stem cell